Holders — by stockHoldings — by fund
Rhenman & Partners Asset Management AB
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001599882
$1.06B
disclosed book value
99
positions
3.7%
largest position share
Positions, as of 2026-06-30
top 99 of 99 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | UNHUNITED HEALTH GROUP INC | 93,600 | $38.9M | 3.7% |
| 2 | CVSCVS HEALTH CORP | 279,374 | $28.9M | 2.7% |
| 3 | AZNASTRAZENECA PLC | 151,500 | $28.5M | 2.7% |
| 4 | MRKMERCK & CO INC | 213,500 | $27.4M | 2.6% |
| 5 | LLYLILLY ELI & CO | 22,315 | $26.8M | 2.5% |
| 6 | ABBVABBVIE INC | 96,775 | $24.4M | 2.3% |
| 7 | ALHCALIGNMENT HEALTHCARE INC | 997,083 | $23.7M | 2.2% |
| 8 | EWEDWARDS LIFESCIENCES CORP | 260,000 | $23.5M | 2.2% |
| 9 | GILDGILEAD SCIENCES INC | 178,250 | $22.5M | 2.1% |
| 10 | JAZZJAZZ PHARMACEUTICALS PLC | 87,440 | $21.1M | 2% |
| 11 | BIIBBIOGEN INC | 94,850 | $20.5M | 1.9% |
| 12 | SYKSTRYKER CORPORATION | 65,000 | $20.5M | 1.9% |
| 13 | BSXBOSTON SCIENTIFIC CORP | 450,500 | $19.2M | 1.8% |
| 14 | JNJJOHNSON & JOHNSON | 72,500 | $18.4M | 1.7% |
| 15 | GHGUARDANT HEALTH INC | 115,000 | $17.3M | 1.6% |
| 16 | REGNREGENERON PHARMACEUTICALS | 27,390 | $17.1M | 1.6% |
| 17 | GKOSGLAUKOS CORP | 119,000 | $16.6M | 1.6% |
| 18 | BMRNBIOMARIN PHARMACEUTICAL INC | 290,500 | $16.6M | 1.6% |
| 19 | NRIXNURIX THERAPEUTICS INC | 684,250 | $16.6M | 1.6% |
| 20 | NTRANATERA INC | 61,050 | $16.6M | 1.6% |
| 21 | MIRMMIRUM PHARMACEUTICALS INC | 139,205 | $16.3M | 1.5% |
| 22 | INSMINSMED INC | 151,960 | $16.2M | 1.5% |
| 23 | THCTENET HEALTHCARE CORP | 85,200 | $15.9M | 1.5% |
| 24 | TMOTHERMO FISHER SCIENTIFIC INC | 31,580 | $15.8M | 1.5% |
| 25 | CNCCENTENE CORP DEL | 244,000 | $15.7M | 1.5% |
| 26 | AXSMAXSOME THERAPEUTICS INC. | 63,050 | $15.4M | 1.5% |
| 27 | DHRDANAHER CORPORATION | 80,252 | $15.3M | 1.4% |
| 28 | VRTXVERTEX PHARMACEUTICALS INC | 30,685 | $15.2M | 1.4% |
| 29 | AVRANTERIS TECHNOLOGIES GLOBAL | 1.5M | $15.2M | 1.4% |
| 30 | NBIXNEUROCRINE BIOSCIENCES INC | 85,841 | $14.5M | 1.4% |
| 31 | PNTGPENNANT GROUP INC | 371,471 | $13.7M | 1.3% |
| 32 | ISRGINTUITIVE SURGICAL INC | 34,500 | $13.7M | 1.3% |
| 33 | ELVELEVANCE HEALTH INC | 34,900 | $13.5M | 1.3% |
| 34 | LIVNLIVANOVA PLC | 164,000 | $13.5M | 1.3% |
| 35 | CORCENCORA INC | 46,778 | $13.2M | 1.2% |
| 36 | CRLCHARLES RIV LABS INTL INC | 57,200 | $13.0M | 1.2% |
| 37 | IDYAIDEAYA Biosciences Inc | 343,800 | $12.8M | 1.2% |
| 38 | MCKMCKESSON CORP | 16,550 | $12.5M | 1.2% |
| 39 | SNDXSYNDAX PHARMACEUTICALS INC | 560,250 | $12.2M | 1.2% |
| 40 | BTSGBRIGHTSPRING HEALTH SVCS INC | 165,896 | $11.6M | 1.1% |
| 41 | MDTMEDTRONIC PLC | 145,000 | $11.3M | 1.1% |
| 42 | MLYSMINERALYS THERAPEUTICS INC | 416,371 | $11.2M | 1.1% |
| 43 | OSCROSCAR HEALTH INC | 392,000 | $11.2M | 1.1% |
| 44 | RPRXROYALTY PHARMA PLC | 197,000 | $11.0M | 1% |
| 45 | DXCMDEXCOM INC | 160,000 | $10.8M | 1% |
| 46 | ALGNALIGN TECHNOLOGY INC | 63,000 | $10.6M | 1% |
| 47 | SYRESPYRE THERAPEUTICS INC | 119,300 | $10.6M | 1% |
| 48 | RLAYRELAY THERAPEUTICS INC | 566,000 | $10.6M | 1% |
| 49 | ARWRARROWHEAD PHARMACEUTICALS IN | 128,000 | $10.4M | 1% |
| 50 | AAGILENT TECHNOLOGIES INC | 75,000 | $10.0M | 0.9% |
| 51 | NKTRNEKTAR THERAPEUTICS | 141,250 | $9.9M | 0.9% |
| 52 | ALKSALKERMES PLC | 185,250 | $9.7M | 0.9% |
| 53 | ABTABBOTT LABORATORIES | 96,000 | $8.7M | 0.8% |
| 54 | DNTHDIANTHUS THERAPEUTICS INC | 86,127 | $8.4M | 0.8% |
| 55 | PRCTPROCEPT BIOROBOTICS CORP | 345,000 | $7.8M | 0.7% |
| 56 | GPCRSTRUCTURE THERAPEUTICS INC | 145,100 | $7.8M | 0.7% |
| 57 | ORKAORUKA THERAPEUTICS INC | 80,000 | $7.6M | 0.7% |
| 58 | EHCENCOMPASS HEALTH CORP | 74,263 | $7.5M | 0.7% |
| 59 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 384,800 | $7.5M | 0.7% |
| 60 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1.7M | $7.1M | 0.7% |
| 61 | BBIOBRIDGEBIO PHARMA INC | 91,100 | $6.8M | 0.6% |
| 62 | KURAKURA ONCOLOGY INC | 591,500 | $6.5M | 0.6% |
| 63 | PODDINSULET CORP | 42,000 | $6.4M | 0.6% |
| 64 | ERASERASCA INC | 349,000 | $6.4M | 0.6% |
| 65 | KRYSKRYSTAL BIOTECH INC | 16,325 | $6.1M | 0.6% |
| 66 | STVNSTEVANATO GROUP S P A | 305,972 | $5.5M | 0.5% |
| 67 | ASTHASTRANA HEALTH INC | 118,888 | $5.5M | 0.5% |
| 68 | CAHCARDINAL HEALTH INC | 22,500 | $5.3M | 0.5% |
| 69 | ALNYALNYLAM PHARMACEUTICALS INC | 17,200 | $5.2M | 0.5% |
| 70 | MOHMOLINA HEALTHCARE INC | 21,857 | $5.0M | 0.5% |
| 71 | VKTXVIKING THERAPEUTICS INC | 128,000 | $5.0M | 0.5% |
| 72 | CITHE CIGNA GROUP | 17,400 | $4.8M | 0.5% |
| 73 | IONSIONIS PHARMACEUTICALS INC | 59,900 | $4.7M | 0.4% |
| 74 | AMNAMN HEALTHCARE SVCS INC | 144,466 | $4.7M | 0.4% |
| 75 | DNLIDENALI THERAPEUTICS INC | 179,000 | $4.6M | 0.4% |
| 76 | MEDPMEDPACE HLDGS INC | 8,500 | $4.5M | 0.4% |
| 77 | MDGLMADRIGAL PHARMACEUTICALS INC | 8,050 | $4.3M | 0.4% |
| 78 | AMGNAMGEN INC | 11,900 | $4.3M | 0.4% |
| 79 | SIONSIONNA THERAPEUTICS INC | 97,100 | $4.3M | 0.4% |
| 80 | ASNDASCENDIS PHARMA A/S | 15,000 | $4.0M | 0.4% |
| 81 | COOCOOPER COS INC | 54,000 | $3.9M | 0.4% |
| 82 | WAYWAYSTAR HLDG CORP | 178,566 | $3.7M | 0.3% |
| 83 | MBXMBX BIOSCIENCES INC | 62,000 | $3.4M | 0.3% |
| 84 | VCELVERICEL CORP | 70,000 | $3.1M | 0.3% |
| 85 | VEEVVEEVA SYS INC | 17,300 | $3.1M | 0.3% |
| 86 | BCAXBICARA THERAPEUTICS INC | 88,150 | $2.6M | 0.2% |
| 87 | STESTERIS PLC | 11,500 | $2.4M | 0.2% |
| 88 | OCULOCULAR THERAPEUTIX INC | 225,000 | $2.2M | 0.2% |
| 89 | STOKSTOKE THERAPEUTICS INC | 64,500 | $2.1M | 0.2% |
| 90 | XENEXENON PHARMACEUTICALS INC | 33,250 | $2.0M | 0.2% |
| 91 | DOCSDOXIMITY INC | 76,107 | $1.6M | 0.1% |
| 92 | PRVAPRIVIA HEALTH GROUP INC | 50,000 | $1.3M | 0.1% |
| 93 | NVCRNOVOCURE LTD | 70,000 | $1.1M | 0.1% |
| 94 | MMEDMINIMED GROUP INC | 55,000 | $822,250 | 0.1% |
| 95 | ATECALPHATEC HLDGS INC | 85,000 | $735,250 | 0.1% |
| 96 | AGLAGILON HEALTH INC | 5,000 | $535,900 | 0.1% |
| 97 | TXG10X GENOMICS INC | 8,500 | $325,890 | 0% |
| 98 | TNDMTANDEM DIABETES CARE INC | 20,000 | $301,800 | 0% |
| 99 | TGTXTG THERAPEUTICS INC | 5,000 | $274,700 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.